37878 Federal Register / Vol. 87, No. 121 / Friday, June 24, 2022 / Notices 

Abstract: HRSA’s Hospital Campaign 

for Organ Donation continues to enlist 

the help of healthcare organizations 

nationwide to increase the number of 

registered organ, eye, and tissue donors 

by hosting education, outreach, and 

donor registration events in their 

facilities and communities. A scorecard 

identifies activities that participants can 

implement and assigns points to each 

activity. Participants that earn a certain 

number of points annually are 

recognized by HRSA and the campaign’s 

national partners. 

Need and Proposed Use of the 

Information: There is a substantial 

imbalance in the U.S. between the more 

than 106,000 people whose lives 

depend on organ transplants and the 

annual number of organ donors 

(approximately 18,000 living and 

deceased donors). This imbalance 

results in approximately 17 deaths per 

day; about 6,200 waiting list deaths 

annually. In addition, a person in need 

of a life-saving or life-improving organ 

transplant is added to the national organ 

transplant waiting list every 9 minutes. 

In response to the need for increased 

donation, HRSA conducts public 

outreach initiatives to encourage the 

American public to enroll on state 

donor registries as future organ donors. 

The scorecard motivates and 

facilitates participation in the campaign, 

provides the basis for rewarding 

participants for their accomplishments, 

and enables HRSA to measure and 

evaluate campaign process and 

outcome. The scorecard also enables 

HRSA to make data-based decisions and 

improvements for subsequent 

campaigns. 

Likely Respondents: Hospital 

development and public relations staff 

of organ procurement and other 

donation organizations; hospital staff 

such as nurses or public relations/ 

communications professionals and staff 

members. Additional respondents may 

include staff at physician’s offices, 

health clinics, and emergency medical 

services; and/or volunteers that 

specifically work with health care 

organizations on organ donation 

initiatives and activities, who may have 

been engaged by or invited through 

word-of-mouth, local organ 

procurement organizations, and/or 

peers, and/or who work within a 

medical and/or health care setting, but 

outside of a hospital environment. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Activity Scorecard (online) ................................................... 1,640 1 1,640 .25 410 

Total .............................................................................. 1,640 ........................ 1,640 ........................ 410 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–13488 Filed 6–23–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; Diversity and Health 

Disparities RFAs review. 

Date: July 15, 2022. 

Time: 8:30 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, 6707 Democracy Blvd., 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Songtao Liu, MD, 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Blvd., Suite 920, MSC 5469, 

Bethesda, MD 20817, (301) 827–3025, 

songato.liu@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, National Institute of 

Biomedical Imaging and Bioengineering, 

National Institutes of Health, HHS) 

Dated: June 17, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–13479 Filed 6–23–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 121 / Friday, June 24, 2022 / Notices 37879 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Hematology and Vascular Biology. 

Date: July 15, 2022. 

Time: 2:00 p.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Larry Pinkus, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4132, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1214, pinkusl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Vascular and Hematology. 

Date: July 19, 2022. 

Time: 2:00 p.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Larry Pinkus, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4132, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1214, pinkusl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: HIV/AIDS Behavioral. 

Date: July 21–22, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ananya Paria, DHSC, 

MPH, MS, Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1007H, 

Bethesda, MD 20892, (301) 827–6513, 

pariaa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 17, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–13477 Filed 6–23–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Medical Imaging Investigations. 

Date: July 26, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yuanna Cheng, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1195, Chengy5@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 17, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–13478 Filed 6–23–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[CBP Dec. 22–13] 

Western Hemisphere Travel Initiative: 

Designation of an Approved Native 

American Tribal Card Issued by the 

Kickapoo Traditional Tribe of Texas as 

an Acceptable Document To Denote 

Identity and Citizenship for Entry in the 

United States at Land and Sea Ports of 

Entry 

AGENCY: U.S. Customs and Border 

Protection, DHS. 

ACTION: Notice. 

SUMMARY: This notice announces that 

the Commissioner of U.S. Customs and 

Border Protection is designating an 

approved Native American tribal card 

issued by the Kickapoo Traditional 

Tribe of Texas to U.S. citizen tribal 

members as an acceptable travel 

document for purposes of the Western 

Hemisphere Travel Initiative. The 

approved card may be used to denote 

identity and citizenship of Kickapoo 

Traditional Tribe of Texas members 

entering the United States from 

contiguous territory or adjacent islands 

at land and sea ports of entry. 

DATES: This designation will become 

effective on June 24, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Adele Fasano, Executive Director, 

Planning, Program Analysis, and 

Evaluation, Office of Field Operations, 

U.S. Customs and Border Protection, via 

email at Adele.Fasano@cbp.dhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Western Hemisphere Travel 

Initiative 

Section 7209 of the Intelligence 

Reform and Terrorism Prevention Act of 

2004 (IRTPA), Public Law 108–458, as 

amended, required the Secretary of 

Homeland Security, in consultation 

with the Secretary of State, to develop 

and implement a plan to require U.S. 

citizens and individuals for whom 

documentation requirements have 

previously been waived under section 

212(d)(4)(B) of the Immigration and 

Nationality Act (8 U.S.C. 1182(d)(4)(B)) 

to present a passport or other document 

or combination of documents as the 

Secretary deems sufficient to denote 

identity and citizenship for all travel 

into the United States. See 8 U.S.C. 1185 

note. On April 3, 2008, the Department 

of Homeland Security (DHS) and the 

Department of State promulgated a joint 

final rule, effective on June 1, 2009, that 


jspears on DSK121TN23PROD with NOTICES1